Z. Draelos, “Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel in Healthy Participants”, J of Skin, vol. 7, no. 4, p. s227, Jul. 2023.